Create Free Account

By creating account you will get access to hot stocks & personalised emails

Mid - Cap

Are you an investor looking for mid-capitalization with sound fundamentals, earnings potential and possibly dividend paying? You are at the right place!

|
One NASDAQ - Listed Cannabis Stock at Resistance Levels: Tilray Brands Inc

One NASDAQ
- Listed Cannabis Stock at Resistance Levels: Tilray Brands Inc

Team Kalkine

One NASDAQ - Listed Cannabis Stock at Resistance Levels: Tilray Brands Inc

  • 12 Sep 2023
  •   | Read Time : 5 min
Technical Analysis on One ASX-Listed Basic Material Stock – M2R

Technical Analysis on One ASX
- Listed Basic Material Stock – M2R

Team Kalkine

Technical Analysis on One ASX-Listed Basic Material Stock – M2R

  • 11 Sep 2023
  •   | Read Time : 5 min
One Petroleum Business May Face Resistance at Current Levels - ALD

One Petroleum Business May Face Resistance at Current Levels
- ALD

Team Kalkine

One Petroleum Business May Face Resistance at Current Levels - ALD

  • 11 Sep 2023
  •   | Read Time : 5 min
One Consumer Staples Stock Likely to Benefit from Retail Network Expansion - MTS

One Consumer Staples Stock Likely to Benefit from Retail Network Expansion
- MTS

Team Kalkine

One Consumer Staples Stock Likely to Benefit from Retail Network Expansion - MTS

  • 08 Sep 2023
  •   | Read Time : 5 mins
Watch Out for NYSE – Listed Communication Stock – Calix Inc

Watch Out for NYSE – Listed Communication Stock – Calix Inc
-

Team Kalkine

Watch Out for NYSE – Listed Communication Stock – Calix Inc

  • 07 Sep 2023
  •   | Read Time : 5 min
One NASDAQ – Listed Biotechnology Stock at Resistance Levels: Insmed Inc

One NASDAQ – Listed Biotechnology Stock at Resistance Levels: Insmed Inc
-

Team Kalkine

One NASDAQ – Listed Biotechnology Stock at Resistance Levels: Insmed Inc

  • 06 Sep 2023
  •   | Read Time : 5 mins
One Consumer Stock Likely to Benefit from Continuing Sales Momentum – EDV

One Consumer Stock Likely to Benefit from Continuing Sales Momentum – EDV
-

Team Kalkine

One Consumer Stock Likely to Benefit from Continuing Sales Momentum – EDV

  • 05 Sep 2023
  •   | Read Time : 5 mins
Technical Analysis on One NASDAQ-Listed Biotechnology Stock- APLS

Technical Analysis on One NASDAQ
- Listed Biotechnology Stock APLS

Team Kalkine

Technical Analysis on One NASDAQ-Listed Biotechnology Stock- APLS

  • 05 Sep 2023
  •   | Read Time : 5 min

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.